Company
Supernus Pharmaceuticals
Innovating CNS Treatments
Also known as Supernus Pharmaceuticals, Inc
- Business model
- B2B
- Legal name
- Supernus Pharmaceuticals, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Supernus, a biopharmaceutical company, develops CNS disease treatments. Transforming patient care with cutting-edge therapies and strategic partnerships.
Funding snapshot
- Total raised
- $30MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $30M2011-01-26
Funding rounds
- Round, 2011
- $30M2011-01-26, SEC form D sold, 3 investors
Loading relationship preview